Tag: Oral Suspension of Hydroxyurea

Pharma major Akums Drugs and Pharmaceuticals has secured a patent for its Room Temperature Stable Oral Suspension of Hydroxyurea, a breakthrough formulation aimed at managing Sickle Cell Disease (SCD). Sickle Cell Disease, a...